CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 5/A Insider Annual Insider Trading Report
- 5/A Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 550,000 shares at $4.50 ($2,475,000)
- 4 Open-market buy Director bought 100,000 shares at $4.50 ($450,000)
- 4 Open-market buy Director bought 100,000 shares at $4.50 ($450,000)
- 4 Open-market buy President and CEO bought 22,222 shares at $4.50 ($99,999)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- CT ORDER Other Confidential Order
- 10-K/A Report 10-K/A
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
Page 53 of 62 · 1,224 filings